Rethinking Obesity: How Novo Nordisk is Rewriting South Africa’s Health Future
Loading player...
🩺 "Obesity is a disease, not a choice - and South Africa is changing the game." - Thabeng Lipeng
In this Social Impact Show interview, Thabeng Lipeng (Director of Market Access & Public Affairs, Novo Nordisk SA) exposes:
✅ The science behind obesity as a treatable chronic condition
✅ Alexandra’s food gardens – Where health equity grows literally
✅ The school obesity pilot rewriting futures (20 schools, 3-year study)
✅ Why insulin access is a human right
In this Social Impact Show interview, Thabeng Lipeng (Director of Market Access & Public Affairs, Novo Nordisk SA) exposes:
✅ The science behind obesity as a treatable chronic condition
✅ Alexandra’s food gardens – Where health equity grows literally
✅ The school obesity pilot rewriting futures (20 schools, 3-year study)
✅ Why insulin access is a human right
